Literature DB >> 26707865

Familiality of Psychotic Disorders: A Polynosologic Study in Multiplex Families.

Victor Peralta1, Ximena Goldberg2, María Ribeiro3, Ana M Sanchez-Torres4, Lourdes Fañanás2, Manuel J Cuesta4.   

Abstract

INTRODUCTION: Phenotype definition of psychotic disorders has a strong impact on the degree of familial aggregation. Nevertheless, the extent to which distinct classification systems affect familial aggregation (ie, familiality) remains an open question. This study was aimed at examining the familiality associated with 4 nosologic systems of psychotic disorders (DSM-IV, ICD-10, Leonhard's classification and a data-driven approach) and their constituting diagnoses in a sample of multiplex families with psychotic disorders.
METHODS: Participants were probands with a psychotic disorder, their parents and at least one first-degree relative with a psychotic disorder. The sample was made of 441 families comprising 2703 individuals, of whom 1094 were affected and 1709 unaffected.
RESULTS: The Leonhard classification system had the highest familiality (h (2) = 0.64), followed by the empirical (h (2) = 0.55), DSM-IV (h (2) = 0.50), and ICD-10 (h (2) = 0.48). Familiality estimates for individual diagnoses varied considerably (h (2) = 0.25-0.79). Regarding schizophrenia diagnoses, Leonhard's systematic schizophrenia (h (2) = 0.78) had the highest familiality, followed by latent class core schizophrenia (h (2) = 0.74), DSM-IV schizophrenia (h (2) = 0.48), and ICD-10 schizophrenia (h (2) = 0.41). Psychotic mood disorders showed substantial familiality across nosologic systems (h (2) = 0.60-0.77). Domains of psychopathology other than reality-distortion symptoms showed moderate familiality irrespective of diagnosis (h (2) = 0.22-0.52) with the deficit syndrome of schizophrenia showing the highest familiality (h (2) = 0.66).
CONCLUSIONS: While affective psychoses showed relatively high familiality estimates across classification schemes, those of nonaffective psychoses varied markedly as a function of the diagnostic scheme with a narrow schizophrenia phenotype maximizing its familial aggregation. Leonhard's classification of psychotic disorders may be better suited for molecular genetic studies than the official diagnostic systems.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  affective psychoses; classification; familial coaggregation; heritability; nosology; schizophrenia

Mesh:

Year:  2015        PMID: 26707865      PMCID: PMC4903050          DOI: 10.1093/schbul/sbv192

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  54 in total

1.  Familial liability and schizophrenia phenotypes: a polydiagnostic approach.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Res       Date:  2007-08-31       Impact factor: 4.939

2.  Current psychopathological issues in psychosis: towards a phenome-wide scanning approach.

Authors:  Manuel J Cuesta; Victor Peralta
Journal:  Schizophr Bull       Date:  2008-05-14       Impact factor: 9.306

Review 3.  The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling.

Authors:  N Risch; J Teng
Journal:  Genome Res       Date:  1998-12       Impact factor: 9.043

4.  Classification of nonschizophrenic psychotic disorders: a historical perspective.

Authors:  A Jablensky
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

5.  Poly-diagnostic approach: a method to clarify incongruences among the classification of the functional psychoses.

Authors:  P Berner; H Katschnig; G Lenz
Journal:  Psychiatr J Univ Ott       Date:  1982-12

6.  The choice of diagnostic criteria for biological research.

Authors:  R E Kendell
Journal:  Arch Gen Psychiatry       Date:  1982-11

7.  A contribution to the validity of Leonhard's classification of endogenous psychoses.

Authors:  G Ungvári
Journal:  Acta Psychiatr Scand       Date:  1985-08       Impact factor: 6.392

8.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

Authors:  A E Farmer; P McGuffin; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1987-07

9.  Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder.

Authors:  Naomi R Wray; Irving I Gottesman
Journal:  Front Genet       Date:  2012-07-02       Impact factor: 4.599

10.  Power and predictive accuracy of polygenic risk scores.

Authors:  Frank Dudbridge
Journal:  PLoS Genet       Date:  2013-03-21       Impact factor: 5.917

View more
  4 in total

Review 1.  Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

Review 2.  Transdiagnostic Extension of Delusions: Schizophrenia and Beyond.

Authors:  Paul Bebbington; Daniel Freeman
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

3.  A neuropsychological study on Leonhard's nosological system.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Gustavo Gil-Berrozpe; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-16       Impact factor: 5.270

Review 4.  Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.

Authors:  Jack R Foucher; Micha Gawlik; Julian N Roth; Clément de Crespin de Billy; Ludovic C Jeanjean; Alexandre Obrecht; Olivier Mainberger; Julie M E Clauss; Julien Elowe; Sébastien Weibel; Benoit Schorr; Marcelo Cetkovich; Carlos Morra; Federico Rebok; Thomas A Ban; Barbara Bollmann; Mathilde M Roser; Markus S Hanke; Burkhard E Jabs; Ernst J Franzek; Fabrice Berna; Bruno Pfuhlmann
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.